Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Senti Biosciences (SNTI) Net Margin (2021 - 2023)

Senti Biosciences (SNTI) has 3 years of Net Margin data on record, last reported at 8.41% in Q4 2023.

  • For Q4 2023, Net Margin rose 2656095.0% year-over-year to 8.41%; the TTM value through Sep 2024 reached 15678.08%, up 1581690.0%, while the annual FY2023 figure was 624.27%, 82364.0% up from the prior year.
  • Net Margin reached 8.41% in Q4 2023 per SNTI's latest filing, down from 6417.75% in the prior quarter.
  • Across five years, Net Margin topped out at 6417.75% in Q3 2023 and bottomed at 26552.54% in Q4 2022.
  • Average Net Margin over 3 years is 2254.66%, with a median of 380.76% recorded in 2021.
  • Peak YoY movement for Net Margin: crashed -2617178bps in 2022, then soared 2656095bps in 2023.
  • A 3-year view of Net Margin shows it stood at 380.76% in 2021, then crashed by -6874bps to 26552.54% in 2022, then surged by 100bps to 8.41% in 2023.
  • Per Business Quant database, its latest 3 readings for Net Margin were 8.41% in Q4 2023, 6417.75% in Q3 2023, and 474.49% in Q2 2023.